Onychomycosis in Diabetics: A Common Infection with Potentially Serious Complications
Aditya K Gupta1,2, Amanda Liddy1, Lee Magal3
1Mediprobe Research Inc., London, ON N5X 2P1, Canada.
Life (Basel, Switzerland)
|August 28, 2025
Summary
Onychomycosis is common in diabetics, increasing risks of infections and foot problems. Early diagnosis and tailored treatments, including antifungals and hygiene, are vital for managing this nail condition.
Area of Science:
- Dermatology
- Endocrinology
- Infectious Diseases
Background:
- Onychomycosis is a frequent complication in diabetic individuals.
- It elevates the risk of secondary infections, foot ulcers, and amputation.
- Prevalence is linked to age, vascular disease, glycemic control, neuropathy, and foot care.
Purpose of the Study:
- To review the epidemiology, diagnosis, and treatment of onychomycosis in diabetic patients.
- To highlight the importance of individualized care for this high-risk population.
Main Methods:
- Literature review summarizing current knowledge on onychomycosis in diabetes.
- Analysis of contributing factors, diagnostic approaches, and therapeutic strategies.
Main Results:
- Diabetics face higher risks of onychomycosis, often with mixed infections (e.g., Candida).
- Systemic antifungals (terbinafine, itraconazole) are first-line for moderate-severe cases.
- Topical agents (efinaconazole, tavaborole) and adjunctive measures are crucial for specific patient groups and recurrence prevention.
Conclusions:
- Individualized treatment plans are essential due to comorbidities and drug interactions.
- Prompt diagnosis and intervention are key to preventing severe complications.
- Comprehensive management, including patient education, improves outcomes for diabetic onychomycosis.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
685
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
685
Skin Diseases and Disorders
4.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.1K
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
Fungal Group Zygomycota
119
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
119


